Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Valsartan Tablets

Approval Number

国药准字H20223428

Company福建海西新药创制股份有限公司

Registration Date

June 28, 2022

Drug Information

Generic Name

缬沙坦片

Dosage Form

片剂

Strength

80mg

Drug Type

化学药品

Registration Date

June 28, 2022

Company Information

Applicant Company

Company Name福建海西新药创制股份有限公司

Company Address

福建省福州市仓山区建新镇金达路177号B座三楼、四楼

Manufacturing Company

Company Name海南先声药业有限公司

Company Address

海南省海口市秀英区药谷三路2号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

缬沙坦片 - NMPA 批准文号 | MedPath